s6y
Company name or ticker
Search
Aligos Therapeutics, Inc.
SC 13D
Versant Venture Capital VI, L.P.: Major Shareholders
Filed
Friday, October 30, 2020
Accession number
0001193125-20-282616
Documents
SC 13D
SC 13D
EX-99.1
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header